Therein lies the problem perhaps.
RGT has changed the focus of its business model maybe 6 times in the last 15 years. All that has done is dilute its ability to maintain momentum.
It was initially a supplier of materials to the EU and is now basically a herbal medicine company having also off-loaded production and distribution to other companies. So, an empty shell really.
Credibility has gone, and any chance of recovery gone as well.
- Forums
- ASX - By Stock
- Ann: Operational and Clinical Development Update
RGT
argent biopharma limited
Add to My Watchlist
0.00%
!
7.8¢

Therein lies the problem perhaps.RGT has changed the focus of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.630M |
Open | High | Low | Value | Volume |
8.1¢ | 8.9¢ | 7.8¢ | $7.476K | 90.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23819 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 27 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23819 | 0.078 |
1 | 8000 | 0.076 |
2 | 23137 | 0.075 |
2 | 57900 | 0.074 |
4 | 75212 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 27 | 1 |
0.089 | 1000 | 1 |
0.090 | 25000 | 1 |
0.095 | 74 | 1 |
0.120 | 18340 | 2 |
Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |